Cholesterol pill tested as new weapon against bowel disease flares
NCT ID NCT05567068
Summary
This study tested whether adding a common cholesterol-lowering drug (atorvastatin) to standard mesalamine treatment could better control ulcerative colitis. It involved 54 adults with mild-to-moderate disease who were not on strong immunosuppressants. Researchers measured if the combination improved patients' quality of life and reduced signs of gut inflammation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Medicine, Mansoura University
Al Mansurah, 35511, Egypt
Conditions
Explore the condition pages connected to this study.